Combining observational and experimental data for causal inference can improve treatment effect estimation. However, many observational data sets cannot be released due to data privacy considerations, so one researcher may not have access to both experimental and observational data. Nonetheless, a small amount of risk of disclosing sensitive…

Reweighting a distribution to minimize a distance to a target distribution is a powerful and flexible strategy for estimating a wide range of causal effects, but can be challenging in practice because optimal weights typically depend on knowledge of the underlying data generating process. In this paper, we focus on design-based weights, which do…

Estimation of causal effects requires making comparisons across groups of observations exposed and not exposed to a a treatment or cause (intervention, program, drug, etc). To interpret differences between groups causally we need to ensure that they have been constructed in such a way that the comparisons are "fair." This can be…

A wide range of machine-learning-based approaches have been developed in the past decade, increasing our ability to accurately model nonlinear and nonadditive response surfaces. This has improved performance for inferential tasks such as estimating average treatment effects in situations where standard parametric models may not fit the data well.…

Randomized controlled trials (RCTs) admit unconfounded design-based inference--randomization largely justifies the assumptions underlying statistical effect estimates--but often have limited sample sizes. However, researchers may have access to big observational data on covariates and outcomes from RCT non-participants. For example, data from A/B…